Global Diverticulitis Market, By Type (Complicated, Uncomplicated, Others), Diagnosis (Imaging Test, Blood/Urine/Stool Test, Liver Test, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Diverticulitis Market Analysis and Size
The global diverticulitis market is expected to witness significant growth during the forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. Rising prevalence of gastrointestinal disorders worldwide and emerging markets are the factors responsible for the growth of this market. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global diverticulitis market in the forecast period 2022-2029. The expected CAGR of global diverticulitis market is tend to be around 8% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Diverticulitis is the type of condition having small, bulging pouches formation in the lining of the digestive system. Many a times, these pouches become infected because of the hard bowel movement, food or bacteria that get stuck in the pockets. Even though the symptoms are mild and treated by lifestyle changes, exercise, and antibiotics but if it get serious the inflamed pouches cause severe abdominal pain, nausea, fever, blood in stools and required surgery.
Diverticulitis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Complicated, Uncomplicated, Others), Diagnosis (Imaging Test, Blood/Urine/Stool Test, Liver Test, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
ANI Pharmaceuticals, Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), Pfizer Inc (U.S.), Mylan N.V. (U.S.), Novartis AG (U.S.), Hikma Pharmaceuticals plc (U.K.), Aurobindo Pharma (India), Allergan (U.S.), Melinta Therapeutics, Inc (U.S.), Cumberland Pharmaceuticals Inc (U.S.), Theravance Biopharma (U.S.), Janssen Global Services, LLC (U.S.), Bristol-Myers Squibb Company (U.S.), GlaxoSmithKline plc. (U.K.), Bayer AG (U.S.)
|
|
Market Opportunities
|
|
Global Diverticulitis Market Dynamics
Drivers
- Increased Incidence of Diverculitis
The increase in the prevalence of the disease boost the market growth. Hence, the demand for medications for faster and better treatment is much more necessary. The rising demand for advanced treatment and the rising population of cigarette smokers are contributing in the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increase in Sedentary Lifestyle
The greater adaptation of the sedentary lifestyle with an immense increase in the gastrointestinal build up the global market analysis. Launching new products has been considered a major factor in creating more opportunities globally. Thus, it is helping in the expansion of the expanded products.
- Increasing Demand for Retail Pharmacies
The rise in the number of narcotic drugs delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to treat the patients with these agents could curb the growth of the global diverticulitis market over a forecast period.
- High Cost
The huge expenditure associated with these agents surely hamper the market growth.
This global diverticulitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global diverticulitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Diverticulitis Market
Considering the present scenario, COVID-19 has left a significant impact on every industry. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.
In the post-pandemic era, commonly used drugs such as hydroxychloroquine have seen a huge surge in demand for the management of COVID-19.The demand for these drugs created huge opportunities for manufacturers of COVID-19 drugs, as a number of developed countries are facing shortage of these drugs.. The socioeconomic stressors have also boosted the demand for these drugs. Thus, this will leave a significant impact on the narcotic drugs market.
Global Diverticulitis Market Scope
The global diverticulitis market is segmented on the basis of type, diagnosis, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Complicated
- Uncomplicated
- Others
Diagnosis
- Imaging Test
- Blood/Urine/Stool Test
- Liver Test
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Diverticulitis Market Regional Analysis/Insights
The global diverticulitis market is analysed and market size insights and trends are provided by type, diagnosis, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global diverticulitis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for diverticulitis market throughout the forecasted period due to increased incidence of gastrointestinal and digestive disorders.
Asia-Pacific dominates the market due to high increased alcohol, smoking & fat consumption and rapidly improving health care infrastructure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Diverticulitis Market Share Analysis
The global diverticulitis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global diverticulitis market
Key players operating in the global diverticulitis market include:
- ANI Pharmaceuticals, Inc. (U.S.)
- Fresenius SE & Co. KGaA (Germany)
- Pfizer Inc (U.S.)
- Mylan N.V. (U.S.)
- Novartis AG (U.S.)
- Hikma Pharmaceuticals plc (U.K.)
- Aurobindo Pharma (India)
- Allergan (U.S.)
- Melinta Therapeutics, Inc (U.S.)
- Cumberland Pharmaceuticals Inc (U.S.)
- Theravance Biopharma (U.S.)
- Janssen Global Services, LLC (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- GlaxoSmithKline plc. (U.K.)
- Bayer AG (U.S.)
SKU-